Franklin Resources Inc. Purchases 350,570 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Franklin Resources Inc. raised its stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 441.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 429,993 shares of the real estate investment trust's stock after purchasing an additional 350,570 shares during the quarter. Franklin Resources Inc. owned 0.16% of Omega Healthcare Investors worth $17,177,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Allworth Financial LP grew its stake in shares of Omega Healthcare Investors by 12.0% in the third quarter. Allworth Financial LP now owns 2,276 shares of the real estate investment trust's stock worth $93,000 after purchasing an additional 244 shares during the last quarter. Venturi Wealth Management LLC grew its position in shares of Omega Healthcare Investors by 29.4% in the 3rd quarter. Venturi Wealth Management LLC now owns 1,259 shares of the real estate investment trust's stock worth $51,000 after buying an additional 286 shares during the last quarter. Cutter & CO Brokerage Inc. increased its stake in shares of Omega Healthcare Investors by 3.7% during the second quarter. Cutter & CO Brokerage Inc. now owns 8,206 shares of the real estate investment trust's stock valued at $281,000 after buying an additional 290 shares during the period. NCP Inc. increased its stake in shares of Omega Healthcare Investors by 10.3% during the second quarter. NCP Inc. now owns 3,310 shares of the real estate investment trust's stock valued at $113,000 after buying an additional 310 shares during the period. Finally, V Square Quantitative Management LLC raised its holdings in shares of Omega Healthcare Investors by 49.5% during the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust's stock valued at $40,000 after acquiring an additional 323 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company's stock.

Insiders Place Their Bets

In other news, CFO Robert O. Stephenson sold 22,542 shares of the business's stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. The trade was a 10.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company's stock.

Analyst Ratings Changes

OHI has been the topic of a number of research analyst reports. Wells Fargo & Company reissued an "overweight" rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Royal Bank of Canada boosted their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a "sector perform" rating in a research report on Monday, November 11th. Scotiabank raised their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "sector perform" rating in a report on Monday, August 26th. Mizuho lifted their price objective on Omega Healthcare Investors from $35.00 to $37.00 and gave the company a "neutral" rating in a research report on Thursday, December 5th. Finally, BMO Capital Markets raised Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 target price for the company in a research report on Monday, December 9th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $40.18.

Omega Healthcare Investors Stock Up 0.1 %

Omega Healthcare Investors stock traded up $0.02 during mid-day trading on Friday, hitting $37.83. The company had a trading volume of 9,425,170 shares, compared to its average volume of 1,720,992. Omega Healthcare Investors, Inc. has a 12 month low of $27.53 and a 12 month high of $44.42. The company has a market capitalization of $10.21 billion, a PE ratio of 27.82, a price-to-earnings-growth ratio of 1.22 and a beta of 0.98. The stock's 50 day moving average price is $40.26 and its two-hundred day moving average price is $38.14. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were given a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 7.08%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors's dividend payout ratio (DPR) is 197.06%.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.